EDGAR Filing Documents for 0001171843-13-002319

Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:

SEC Accession No. 0001171843-13-002319

Filing Date

2013-05-30

Accepted

2013-05-29 18:25:32

Documents

Period of Report

2013-02-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 40-F	f40f_052713.htm	40-F	53647
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	617173
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	1069588
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	372954
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	28206
6	EXHIBIT 99.5	exh_995.htm	EX-99.5	10259
7	EXHIBIT 99.6	exh_996.htm	EX-99.6	10591
8	EXHIBIT 99.7	exh_997.htm	EX-99.7	10848
9	EXHIBIT 99.8	exh_998.htm	EX-99.8	5370
10	EXHIBIT 99.9	exh_999.htm	EX-99.9	4931
11		kpmg.jpg	GRAPHIC	5369
12		kpmgsig.jpg	GRAPHIC	4884
13		logo.gif	GRAPHIC	7105
14		logobig.jpg	GRAPHIC	54580
	Complete submission text file	0001171843-13-002319.txt		2284148

Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3

Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)